Trial NCT02993991

View at ClinicalTrials.gov 
Org. Study IDs: PRIMED-001

Last trial update was posted on 2017-12-29

MeSH Interventions

Durvalumab Mocetinostat

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Squamous Cell Carcinoma of Head and Neck

Other Conditions

Resectable Squamous Cell Carcinoma of Oral Cavity Squamous Cell Carcinoma Mouth Squamous Cell Carcinoma, Head And Neck

Stopping Reasons

The study has been terminated due to a change in internal prioritization and not due to any safety concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID